Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Abiomed stock
Learn how to easily invest in Abiomed stock.
Abiomed Inc is a medical devices business based in the US. Abiomed shares (ABMD) are listed on the NASDAQ and all prices are listed in US Dollars. Abiomed employs 1,725 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Abiomed
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ABMD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Abiomed stock price (NASDAQ: ABMD)Use our graph to track the performance of ABMD stocks over time.
Abiomed shares at a glance
|Latest market close||$277.30|
|52-week range||$261.27 - $387.40|
|50-day moving average||$332.23|
|200-day moving average||$327.79|
|Wall St. target price||$384.40|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$3.26|
Buy Abiomed shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Abiomed stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Abiomed price performance over time
|1 week (2022-01-20)||-8.41%|
|1 month (2021-12-24)||N/A|
|3 months (2021-10-27)||-19.53%|
|6 months (2021-07-28)||-14.36%|
|1 year (2021-01-28)||-21.92%|
|2 years (2020-01-28)||48.28%|
|3 years (2019-01-28)||336.9|
|5 years (2017-01-27)||154.75%|
Is Abiomed stock undervalued or overvalued?
Valuing Abiomed stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abiomed's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Abiomed's P/E ratio
Abiomed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 93x. In other words, Abiomed shares trade at around 93x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Abiomed's PEG ratio
Abiomed's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.75. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Abiomed's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Abiomed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $288.2 million.
The EBITDA is a measure of a Abiomed's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$973.6 million|
|Operating margin TTM||26.92%|
|Gross profit TTM||$685.6 million|
|Return on assets TTM||11.46%|
|Return on equity TTM||11.62%|
|Market capitalisation||$13.7 billion|
TTM: trailing 12 months
Abiomed share dividends
We're not expecting Abiomed to pay a dividend over the next 12 months.
Have Abiomed's shares ever split?
Abiomed's shares were split on a 2:1 basis on 1 October 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Abiomed shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Abiomed shares which in turn could have impacted Abiomed's share price.
Abiomed share price volatility
Over the last 12 months, Abiomed's shares have ranged in value from as little as $261.27 up to $387.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abiomed's is 1.2945. This would suggest that Abiomed's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2. 5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5. 0, Impella LD, and Impella 5.
Abiomed in the news
Ackman takes a big stake in Netflix, excited about company's long-term prospects
What to watch today: Stock futures turn positive, reversing big overnight losses
5 things to know before the stock market opens Thursday
Frequently asked questionsWhat percentage of Abiomed is owned by insiders or institutions?
Currently 2.059% of Abiomed shares are held by insiders and 92.657% by institutions. How many people work for Abiomed?
Latest data suggests 1,725 work at Abiomed. When does the fiscal year end for Abiomed?
Abiomed's fiscal year ends in March. Where is Abiomed based?
Abiomed's address is: 22 Cherry Hill Drive, Danvers, MA, United States, 01923 What is Abiomed's ISIN number?
Abiomed's international securities identification number is: US0036541003 What is Abiomed's CUSIP number?
Abiomed's Committee on Uniform Securities Identification Procedures number is: 003654100
More guides on Finder
Cathie Wood’s ARK analysts predict Bitcoin at $1 million each by 2030
Five major factors contribute to the continued bull run of Bitcoin, ARK says, including growing adoption and long-term focus of investors.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Stocks are dropping; 3 rules for buying on the dip
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
The crypto market has lost $1.5 trillion in value — time to buy?
The crypto market wiped out $1.5 trillion in value in just three months.
Bitcoin tumbles past $40,000, altcoins follow
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s Pavia plot sale shows land rush is on in the metaverse
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
Ask an Expert